cholesteryl butanoate has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera, G; Chiocchetti, A; Conti, L; Dianzani, C; Dianzani, U; Fantozzi, R; Gasco, P; Gigliotti, CL; Giovarelli, M; Minelli, R; Occhipinti, S; Zara, GP | 1 |
| Barrera, G; Dianzani, C; Dianzani, U; Fantozzi, R; Gasco, P; Gigliotti, C; Mesturini, R; Minelli, R; Minero, V; Muntoni, E; Pettazzoni, P; Rosa, AC; Serpe, L; Vivenza, N; Zara, GP | 1 |
2 other study(ies) available for cholesteryl butanoate and Colonic Neoplasms
| Article | Year |
|---|---|
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol Esters; Colonic Neoplasms; Female; Humans; Lipids; Male; Mice; Mice, SCID; Nanoparticles; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2013 |
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.
Topics: Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cholesterol Esters; Colonic Neoplasms; Drug Carriers; Human Umbilical Vein Endothelial Cells; Humans; Nanoparticles | 2012 |